Curative Study of Chinese Traditional Medicine to Treat Lung Cancer

NCT02777788 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

DRUG: JinFuKang
DRUG: XingZaoRuanJian
DRUG: pemetrexed,docetaxel,gemcitabine,paclitaxel or vinorelbine combined with carboplatin、cis-platinum or nedaplatin

Sponsor

Shanghai University of Traditional Chinese Medicine

Collaborators

[object Object]
[object Object]